Generation of HLA-deficient platelets from hematopoietic progenitor cells

Transfusion

Volumn 50, Issue 8, 2010, Pages 1690-1701

  Figueiredo, Constança ^a,b,c   Goudeva, Lilia ^a,b,c   Horn, Peter A ^a,b,c   Eiz Vesper, Britta ^a,b,c   Blasczyk, Rainer ^a,b,c   Seltsam, Axel ^a,b,c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c Institute Springe   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CD34 ANTIGEN; GREEN FLUORESCENT PROTEIN; HLA ANTIGEN CLASS 1; INTERLEUKIN 3; LENTIVIRUS VECTOR; SHORT HAIRPIN RNA; THROMBOPOIETIN;

ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MEGAKARYOCYTE; MICROSCOPY; NORMAL HUMAN; PROTEIN EXPRESSION; RNA INTERFERENCE; SEQUENCE ANALYSIS; THROMBOCYTE; ANTAGONISTS AND INHIBITORS; CYTOLOGY; GENE SILENCING; IMMUNOLOGY; PHYSIOLOGY; THROMBOCYTE TRANSFUSION;

BETA 2-MICROGLOBULIN; GENE SILENCING; HEMATOPOIETIC STEM CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MEGAKARYOCYTES; PLATELET TRANSFUSION; RNA INTERFERENCE;

EID: 77955168172     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02644.x     Document Type: Article

References (37)

1. Gulliksson H, AuBuchon JP, Vesterinen M, Sandgren P, Larsson S, Pickard CA, Herschel I, Roger J, Tracy JE, Langweiler M Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion. Storage of platelets in additive solutions: a pilot in vitro study of the effects of potassium and magnesium. Vox Sang 2002 82 : 131 6.
2. Blumberg N, Heal JM, Liesveld JL, Phillips GL, Rowe JM. Platelet transfusion and survival in adults with acute leukemia. Leukemia 2007 22 : 631 5.
3. Nevo S, Fuller AK, Zahurak ML, Hartley E, Borinsky ME, Vogelsang GB. Profound thrombocytopenia and survival of hematopoietic stem cell transplant patients without clinically significant bleeding, using prophylactic platelet transfusion triggers of 10 x 10(9) or 20 x 10(9) per L. Transfusion 2007 47 : 1700 9.
4. Stephan F, Montblanc J, Cheffi A, Bonnet F. Thrombocytopenia in critically ill surgical patients: a case-control study evaluating attributable mortality and transfusion requirements. Crit Care 1999 3 : 151 8.
5. Rebulla P. Refractoriness to platelet transfusion. Curr Opin Hematol 2002 9 : 516 20.
6. Kiefel V, Konig C, Kroll H, Santoso S. Platelet alloantibodies in transfused patients. Transfusion 2001 41 : 766 70.
7. Laundy GJ, Bradley BA, Rees BM, Younie M, Hows JM. Incidence and specificity of HLA antibodies in multitransfused patients with acquired aplastic anemia. Transfusion 2004 44 : 814 25.
8. Matsunaga T, Tanaka I, Kobune M, Kawano Y, Tanaka M, Kuribayashi K, Iyama S, Sato T, Sato Y, Takimoto R, Takayama T, Kato J, Ninomiya T, Hamada H, Niitsu Y. Ex vivo large-scale generation of human platelets from cord blood CD34+ cells. Stem Cells 2006 24 : 2877 87.
9. Norol F, Vitrat N, Cramer E, Guichard J, Burstein SA, Vainchenker W, Debili N. Effects of cytokines on platelet production from blood and marrow CD34+ cells. Blood 1998 91 : 830 43.
10. Fujimoto TT, Kohata S, Suzuki H, Miyazaki H, Fujimura K. Production of functional platelets by differentiated embryonic stem (ES) cells in vitro. Blood 2003 102 : 4044 51.
11. Nishikii H, Eto K, Tamura N, Hattori K, Heissig B, Kanaji T, Sawaguchi A, Goto S, Ware J, Nakauchi H. Metalloproteinase regulation improves in vitro generation of efficacious platelets from mouse embryonic stem cells. J Exp Med 2008 205 : 1917 27.
12. Takayama N, Nishikii H, Usui J, Tsukui H, Sawaguchi A, Hiroyama T, Eto K, Nakauchi H. Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors. Blood 2008 111 : 5298 306.
13. Abbas-Terki T, Blanco-Bose W, Deglon N, Pralong W, Aebischer P. Lentiviral-mediated RNA interference. Hum Gene Ther 2002 13 : 2197 201.
14. Taulli R, Accornero P, Follenzi A, Mangano T, Morotti A, Scuoppo C, Forni PE, Bersani F, Crepaldi T, Chiarle R, Naldini L, Ponzetto C. RNAi technology and lentiviral delivery as a powerful tool to suppress Tpr-Met-mediated tumorigenesis. Cancer Gene Ther 2005 12 : 456 63.
15. Kock N, Kasmieh R, Weissleder R, Shah K. Tumor therapy mediated by lentiviral expression of shBcl-2 and S-TRAIL. Neoplasia 2007 9 : 435 42.
16. Figueiredo C, Seltsam A, Blasczyk R. Class-, gene-, and group-specific HLA silencing by lentiviral shRNA delivery. J Mol Med 2006 84 : 425 37.
17. Italiano JE, Jr., Lecine P, Shivdasani RA, Hartwig JH. Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes. J Cell Biol 1999 147 : 1299 312.
18. Ungerer M, Peluso M, Gillitzer A, Massberg S, Heinzmann U, Schulz C, Münch G, Gawaz M. Generation of functional culture-derived platelets from CD34+ progenitor cells to study transgenes in the platelet environment. Circ Res 2004 95 : e36 44.
19. Giarratana MC, Kobari L, Lapillonne H, Chalmers D, Kiger L, Cynober T, Marden MC, Wajcman H, Douay L. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol 2005 23 : 69 74.
20. Baek EJ, Kim HS, Kim S, Jin H, Choi TY, Kim HO. In vitro clinical-grade generation of red blood cells from human umbilical cord blood CD34+ cells. Transfusion 2008 48 : 2235 45.
21. Dorn I, Lazar-Karsten P, Boie S, Ribbat J, Hartwig D, Driller B, Kirchner H, Schlenke P. In vitro proliferation and differentiation of human CD34+ cells from peripheral blood into mature red blood cells with two different cell culture systems. Transfusion 2008 48 : 1122 32.
22. Neildez-Nguyen TM, Wajcman H, Marden MC, Bensidhoum M, Moncollin V, Giarratana MC, Kobari L, Thierry D, Douay L. Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo. Nat Biotechnol 2002 20 : 467 72.
23. Choi ES, Nichol JL, Hokom MM, Hornkohl AC, Hunt P. Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood 1995 85 : 402 13.
24. Lu SJ, Feng Q, Park JS, Vida L, Lee BS, Strausbauch M, Wettstein PJ, Honig GR, Lanza R. Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood 2008 112 : 4475 84.
25. Olivier EN, Qiu C, Velho M, Hirsch RE, Bouhassira EE. Large-scale production of embryonic red blood cells from human embryonic stem cells. Exp Hematol 2006 34 : 1635 42.
26. Bagnis C, Chapel S, Chiaroni J, Bailly P. A genetic strategy to control expression of human blood group antigens in red blood cells generated in vitro. Transfusion 2009.
27. Shanwell A, Sallander S, Olsson I, Gulliksson H, Pedajas I, Lerner R. An alloimmunized, thrombocytopenic patient successfully transfused with acid-treated, random-donor platelets. Br J Haematol 1991 79 : 462 5.
28. Bertolini F, Porretti L, Corsini C, Rebulla P, Sirchia G. Platelet quality and reduction of HLA expression in acid-treated platelet concentrates. Br J Haematol 1993 83 : 525 7.
29. Novotny VM, Doxiadis IN, van Doorn R, Brand A. The kinetics of HLA Class I elution and the relevance for the use of HLA-eluted platelet transfusions. Br J Haematol 1996 95 : 416 22.
30. Castro E, Muncunill J, Barea L, Gonzalez R, Fernandez-Villalta MJ. Acid elution of platelets HLA-Class I antigens in the treatment of a refractory patient. Br J Haematol 1998 100 : 245 6.
31. Novotny VM, Huizinga TW, van Doorn R, Briet E, Brand A. HLA Class I-eluted platelets as an alternative to HLA-matched platelets. Transfusion 1996 36 : 438 44.
32. Figueiredo C, Horn PA, Blasczyk R, Seltsam A. Regulating MHC expression for cellular therapeutics. Transfusion 2007 47 : 18 27.
33. Cosgrove LJ, Vaughan HA, Tjandra JJ, Thurlow PJ, McKenzie IF. HLA (Class I) antigens on platelets are involved in platelet function. Immunol Cell Biol 1988 66 : 69 77.
34. Rubinstein E, Urso I, Boucheix C, Carroll RC. Platelet activation by cross-linking HLA Class I molecules and Fc receptor. Blood 1992 79 : 2901 8.
35. Baum C, Dullmann J, Li Z, Fehse B, Meyer J, Williams DA, von Kalle C. Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 2003 101 : 2099 114. (Pubitemid 36302043)
36. Cavazzana-Calvo M, Fischer A. Gene therapy for severe combined immunodeficiency: are we there yet? J Clin Invest 2007 117 : 1456 65.
37. Ott MG, Schmidt M, Schwarzwaelder K, Stein S, Siler U, Koehl U, Glimm H, Kühlcke K, Schilz A, Kunkel H, Naundorf S, Brinkmann A, Deichmann A, Fischer M, Ball C, Pilz I, Dunbar C, Du Y, Jenkins NA, Copeland NG, Lüthi U, Hassan M, Thrasher AJ, Hoelzer D, von Kalle C, Seger R, Grez M. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 2006 12 : 401 9.